Company / Working Capital per Share
Apogee Therapeutics, Inc. Working Capital per Share History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$9.08
FY2024
5-year range
$9.08 / $57.70
FY2022-FY2024
Trend
-39.9%
vs FY2023
Sector context
#57 of 210
Health Care
What the data says
At $9.08, Apogee Therapeutics, Inc.'s working capital per share ranks #57 of 210 in the Health Care sector. Declined from $57.70 to $9.08 over the past 2 years.
Based on SEC 10-K filings.
9.08 in FY2024.
Declined from $57.70 to $9.08 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#57 of 210 in Health CareTop 27% of 210This company $9.08 Sector average $146.86
▼
-93.8% below sector average
Key checks
Key Insights
- In FY2024, working capital per share decreased 39.9% year-over-year.
- Ranks #57 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $9.08 | -39.9% |
| FY2023 | $15.11 | -73.8% |
| FY2022 | $57.70 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026